2-甲氧基-3-丁烯-1-醇 | 18231-00-0

• 分子结构分类: 有机化合物 - 有机氧化合物
• 中文名称: 2-甲氧基-3-丁烯-1-醇
• 英文名称: 2-(R)-2-Methoxybut-3-en-1-ol
• 英文别名: 2-methoxy-but-3-en-1-ol；2-methoxy-3-buten-1-ol；2-methoxybut-3-en-1-ol；erythrol-2-methyl ether；Erythrol-2-methylaether；R-2-methoxy-3-butene-1-ol
• CAS: 18231-00-0
• 化学式: C₅H₁₀O₂
• mdl: MFCD00142937
• 分子量: 102.133
• InChiKey: CWSWWBPJNKCKBO-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  0.1
• 重原子数：
  7
• 可旋转键数：
  3
• 环数：
  0.0
• sp3杂化的碳原子比例：
  0.6
• 拓扑面积：
  29.5
• 氢给体数：
  1
• 氢受体数：
  2

安全信息

• 海关编码：
  2909499000

SDS

Name:	2-Methoxy-3-Butene-1-ol Material Safety Data Sheet
Synonym:	None
CAS:	18231-00-0

Section 1 - Chemical Product MSDS Name:2-Methoxy-3-Butene-1-ol Material Safety Data Sheet
Synonym:None

---

Section 2 - COMPOSITION, INFORMATION ON INGREDIENTS

CAS#	Chemical Name	content	EINECS#
18231-00-0	2-Methoxy-3-Butene-1-ol	ca 100	unlisted

Hazard Symbols: None Listed.
Risk Phrases: None Listed.

---

Section 3 - HAZARDS IDENTIFICATION
EMERGENCY OVERVIEW
The toxicological properties of this material have not been fully investigated.
Potential Health Effects
Eye:
May cause eye irritation. The toxicological properties of this material have not been fully investigated.
Skin:
May cause skin irritation. The toxicological properties of this material have not been fully investigated.
Ingestion:
May cause irritation of the digestive tract. The toxicological properties of this substance have not been fully investigated.
Inhalation:
May cause respiratory tract irritation. The toxicological properties of this substance have not been fully investigated.
Chronic:
No information found.

---

Section 4 - FIRST AID MEASURES
Eyes: Flush eyes with plenty of water for at least 15 minutes, occasionally lifting the upper and lower eyelids. Get medical aid.
Skin:
Get medical aid. Flush skin with plenty of water for at least 15 minutes while removing contaminated clothing and shoes. Wash clothing before reuse.
Ingestion:
Never give anything by mouth to an unconscious person. Get medical aid. Do NOT induce vomiting. If conscious and alert, rinse mouth and drink 2-4 cupfuls of milk or water.
Inhalation:
Remove from exposure and move to fresh air immediately. If not breathing, give artificial respiration. If breathing is difficult, give oxygen. Get medical aid.
Notes to Physician:

---

Section 5 - FIRE FIGHTING MEASURES
General Information:
As in any fire, wear a self-contained breathing apparatus in pressure-demand, MSHA/NIOSH (approved or equivalent), and full protective gear. During a fire, irritating and highly toxic gases may be generated by thermal decomposition or combustion.
Extinguishing Media:
Use agent most appropriate to extinguish fire. Use water spray, dry chemical, carbon dioxide, or appropriate foam.

---

Section 6 - ACCIDENTAL RELEASE MEASURES
General Information: Use proper personal protective equipment as indicated in Section 8.
Spills/Leaks:
Clean up spills immediately, observing precautions in the Protective Equipment section. Sweep up or absorb material, then place into a suitable clean, dry, closed container for disposal. Provide ventilation.

---

Section 7 - HANDLING and STORAGE
Handling:
Wash thoroughly after handling. Remove contaminated clothing and wash before reuse. Use with adequate ventilation. Avoid contact with eyes, skin, and clothing. Keep container tightly closed. Avoid ingestion and inhalation.
Storage:
Store in a tightly closed container. Store in a cool, dry, well-ventilated area away from incompatible substances.

---

Section 8 - EXPOSURE CONTROLS, PERSONAL PROTECTION
Engineering Controls:
Use adequate ventilation to keep airborne concentrations low.
Exposure Limits CAS# 18231-00-0: Personal Protective Equipment Eyes: Wear appropriate protective eyeglasses or chemical safety goggles as described by OSHA's eye and face protection regulations in 29 CFR 1910.133 or European Standard EN166.
Skin:
Wear appropriate protective gloves to prevent skin exposure.
Clothing:
Wear appropriate protective clothing to prevent skin exposure.
Respirators:
Follow the OSHA respirator regulations found in 29 CFR 1910.134 or European Standard EN 149. Use a NIOSH/MSHA or European Standard EN 149 approved respirator if exposure limits are exceeded or if irritation or other symptoms are experienced.

---

Section 9 - PHYSICAL AND CHEMICAL PROPERTIES

Physical State: Not available.
Color: Not available.
Odor: Not available.
pH: Not available.
Vapor Pressure: Not available.
Viscosity: Not available.
Boiling Point: Not available.
Freezing/Melting Point: 0 deg C
Autoignition Temperature: Not available.
Flash Point: Not available.
Explosion Limits, lower: Not available.
Explosion Limits, upper: Not available.
Decomposition Temperature:
Solubility in water:
Specific Gravity/Density:
Molecular Formula: C5H10O2
Molecular Weight: 102.13

---

Section 10 - STABILITY AND REACTIVITY
Chemical Stability:
Stable under normal temperatures and pressures.
Conditions to Avoid:
Incompatible materials, strong oxidants.
Incompatibilities with Other Materials:
Oxidizing agents.
Hazardous Decomposition Products:
Carbon monoxide, irritating and toxic fumes and gases, carbon dioxide.
Hazardous Polymerization: Has not been reported

---

Section 11 - TOXICOLOGICAL INFORMATION
RTECS#:
CAS# 18231-00-0 unlisted.
LD50/LC50:
Not available.
Carcinogenicity:
2-Methoxy-3-Butene-1-ol - Not listed by ACGIH, IARC, or NTP.

---

Section 12 - ECOLOGICAL INFORMATION

---

Section 13 - DISPOSAL CONSIDERATIONS
Dispose of in a manner consistent with federal, state, and local regulations.

---

Section 14 - TRANSPORT INFORMATION

IATA
Not regulated as a hazardous material.
IMO
Not regulated as a hazardous material.
RID/ADR
Not regulated as a hazardous material.

---

Section 15 - REGULATORY INFORMATION

European/International Regulations
European Labeling in Accordance with EC Directives
Hazard Symbols: Not available.
Risk Phrases:
Safety Phrases:
S 24/25 Avoid contact with skin and eyes.
S 28A After contact with skin, wash immediately with
plenty of water.
S 37 Wear suitable gloves.
S 45 In case of accident or if you feel unwell, seek
medical advice immediately (show the label where
possible).
WGK (Water Danger/Protection)
CAS# 18231-00-0: No information available.
Canada
None of the chemicals in this product are listed on the DSL/NDSL list.
CAS# 18231-00-0 is not listed on Canada's Ingredient Disclosure List.
US FEDERAL
TSCA
CAS# 18231-00-0 is not listed on the TSCA inventory.
It is for research and development use only.

---

SECTION 16 - ADDITIONAL INFORMATION
N/A

反应信息

• 作为反应物：
  描述：

  2-甲氧基-3-丁烯-1-醇 在 氯仿 、 溴 作用下， 生成 3,4-dibromo-2-methoxy-butan-1-ol
  参考文献：
  名称：

  Petrow, Zhurnal Obshchei Khimii, 1946, vol. 16, p. 1629

  摘要：

  DOI：
• 作为产物：
  描述：

  tert-butyl-(2-methoxybut-3-enoxy)-dimethylsilane 在 四丁基氟化铵 作用下， 以 四氢呋喃 为溶剂， 反应 4.0h， 以64%的产率得到2-甲氧基-3-丁烯-1-醇
  参考文献：
  名称：

  Development of a Concise and Diversity-Oriented Approach for the Synthesis of Plecomacrolides via the Diene−Ene RCM

  摘要：

  A concise synthesis of the core structures of plecomacrolide with ring sizes varying from 16 to 19 atoms was achieved for the first time by the diene-ene ring-closing olefin metathesis reaction. This approach should allow access to the structurally diverse analogues of plecomacrolide.

  DOI：

  10.1021/ol060221v

文献信息

• Macrocyclic kinase inhibitors
  申请人：Lin Nan-Horng

  公开号：US20050215556A1

  公开（公告）日：2005-09-29

  Compounds having the formula are useful for inhibiting protein kinases. Also disclosed are methods of making the compounds, compositions containing the compounds, and methods of treatment using the compounds.

  具有以下化学式的化合物对抑制蛋白激酶很有用。还公开了制备这些化合物的方法、含有这些化合物的组合物，以及使用这些化合物进行治疗的方法。
• Thia-acyliminium cyclisations
  作者：J.A.M. Hamersma、P.M.M. Nossin、W.N. Speckamp

  DOI：10.1016/s0040-4020(01)96567-6

  日期：1985.1

  by the intermediacy of N-acyliminium species. A similar process applied to lactams 21b–25b affords the pyrrolizidine type compounds 26–35 through consecutive azonium-Cope rearrangement and N-acyliminium ring closure. Additional results are concerned with the use of aromatic rings as π-nucleophiles.

  通过内酰胺类物种的中间作用，羧甲基内酰胺1b–3b的环化可提供高产的大环化合物4–6。应用于内酰胺21b-25b的类似过程可通过连续的偶氮鎓Cope重排和N-嘧啶闭环得到吡咯烷核苷类化合物26-35。其他结果涉及芳环作为π-亲核试剂的使用。
• Method for producing a fluorinated ester compound
  申请人：ASAHI GLASS COMPANY LIMITED

  公开号：US20030216595A1

  公开（公告）日：2003-11-20

  The present invention provides a method for producing industrially useful fluorine-containing compounds such as a fluorinated ester compound and an acid fluoride compound. Namely, the present invention resides in a method for producing a fluorinated ester compound, which comprises fluorinating an ester compound which is an ester of a compound having hydroxyl group(s) with a compound having acyl fluoride group(s) and which has a structure which can be fluorinated, in a liquid phase to produce a fluorinated ester compound, wherein the fluorination is carried out in the form of a liquid mixture of the ester compound and the compound having acyl fluoride group(s).

  本发明提供了一种生产工业上有用的含氟化合物，如含氟酯化合物和酸氟化合物的方法。 即，本发明涉及一种生产含氟酯化合物的方法，包括在液相中将含有羟基的化合物的酯与含有酰氟基的化合物氟化，以产生含氟酯化合物，其中氟化是以酯化合物和含有酰氟基的化合物的液相混合物的形式进行的。
• Polymers of 3-butene esters, their preparation and use
  申请人：Eastman Chemical Company

  公开号：US06348623B2

  公开（公告）日：2002-02-19

  The specification describes various polymers having monomer of formula (I): In formula (I), R1 and R2 are, independently, hydrogen, a C1-C24 alkyl group, an aromatic or heteroaromatic group, a C3-C8 cycloalkyl or C2-C7 heterocycloalkyl group, or a —C(O)R3 group in which R3 is a C1-C24 alkyl group, an aromatic or heteroaromatic group, a C3-C8 cycloalkyl or C2-C7 heterocyclic group; or a —CH2—C(O)—R4 group in which R4 is a C1-C6 alkyl group. At least one of R1 and R2 is a —C(O)R3 group. The polymer may be a homopolymer or a copolymer containing other ethylenically unsaturated monomers. The polymer may be used in a variety of coating compositions such as inks, adhesives, paints and films. Unique monomers where both R1 and R2 are acetoacetyl groups and novel monomers where R2 is an acetoacetyl group are also described.

  规范描述了具有式(I)的单体的各种聚合物：在式(I)中，R1和R2独立地是氢、C1-C24烷基、芳香或杂芳基、C3-C8环烷基或C2-C7杂环烷基、或者—C(O)R3基团，其中R3是C1-C24烷基、芳香或杂芳基、C3-C8环烷基或C2-C7杂环基；或者—CH2—C(O)—R4基团，其中R4是C1-C6烷基。R1和R2中至少有一个是—C(O)R3基团。该聚合物可以是含有其他乙烯基不饱和单体的均聚物或共聚物。该聚合物可以用于各种涂料组合物，如油墨、粘合剂、油漆和薄膜。还描述了R1和R2均为乙酰乙酰基团的独特单体以及R2为乙酰乙酰基团的新型单体。
• Flexible metathesis-based approaches to highly functionalised furans and pyrroles
  作者：Timothy J. Donohoe、Neil M. Kershaw、Allan J. Orr、Katherine M.P. Wheelhouse (nee Gosby)、Lisa P. Fishlock、Adam R. Lacy、Matilda Bingham、Panayiotis A. Procopiou

  DOI：10.1016/j.tet.2007.09.087

  日期：2008.1.28

  have been synthesised in short order by the judicious use of a ring-closing metathesis/aromatisation strategy. Two contrasting approaches are described exploiting a palladium-catalysed union of allylic alcohols and sulfonamides in one case, and a titanium mediated methylenation of homoallylic esters in another. A number of groups that are difficult to install via traditional methods were incorporated

  通过明智地使用闭环复分解/芳构化策略，已在短时间内合成了一系列功能不同的呋喃和吡咯。描述了两种对比方法，一种是利用钯催化的烯丙基醇和磺酰胺的结合，另一种是利用钛介导的均烯丙基酯的甲基化。通过传统方法难以安装的许多组已成功合并。